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repair.
Patients and methods: This randomized double-blind controlled trial was done in department of
anesthesia, Cairo University hospitals, and 40 patients with ASA physical status classiﬁcation
I–II, aged 2–7 years were enrolled in this study and randomly assigned into 2 groups; group L
received caudal levobupivacaine 1 ml/kg with concentration of 0.25% and group LN received
caudal 0.125% levobupivacaine with volume of 1 ml/kg plus 0.2 mg/kg nalbuphine. Pain was
evaluated immediately after emergence (FLACC 0 h), after 1 h in the PACU, after 2, 3, 4, 5, 6
and 12 h by the FLACC pain score (Face, Leg, Activity, Crying, Consolability). First time of rescue
analgesic, total dose of rescue analgesic and side effects were observed for 12 h.
Results: FLACC pain scores were much less in LN group compared to L group (p value < 0.001)
after the second hour. The ﬁrst time for postoperative analgesic requirement was signiﬁcantly longer
in LN group (384 ± 23.1 min) compared to L group (202.20 ± 23.42 min) (p value > 0.001). The
total dose of postoperative supplementary analgesia (intravenous paracetamol infusion) in the ﬁrst
12 h was signiﬁcantly lower in LN group (200.5 ± 65.5 mg) in comparison with L group (355.25 ±
69.9 mg) (P< 0.05).
Conclusions: Combining caudal anesthesia using levobupivacaine and nalbuphine provided
prolonged time of analgesia with no reported side effects.
 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
It has been demonstrated that caudal analgesia is the most
common regional anesthetic block practiced in children [1].
84 A.K. SalamaIt is proved to be effective, reliable and safe; it can be used as
adjunct to general anesthesia to provide perioperative analge-
sia in procedures below the umbilicus as herniotomy and
penile surgeries [2]. Application of single local anesthetic drug
for caudal analgesia requires high dose but this may provoke
side effects such as respiratory depression, hypotension and
local anesthetic toxicity [3]. So more than one agent may be
used to solve this problem and help using low doses of local
anesthetic. Various drugs have been used with levobupivacaine
to prolong its duration of action and to decrease the side
effects. Levobupivacaine, a new long-acting amide local anes-
thetic, is the S ()-isomer of the racemic bupivacaine. Unlike
bupivacaine, it is less toxic to the central nervous system and
less likely to cause myocardial depression and fatal arrhyth-
mias [4].
Nalbuphine is a mixed j-agonist and l-antagonist opioid of
the phenanthrene group; it is related chemically to naloxone
and oxymorphone. Nalbuphine leads to activation of spinal
and supraspinal opioid receptors which leads to good analgesia
with minimal sedation, minimal nausea and vomiting, less res-
piratory depression and stable cardiovascular functions [5].
Safety and efﬁcacy of nalbuphine have been established in
the clinical ﬁeld [6] and its safety and efﬁcacy also established
via the epidural route [7].
Nalbuphine being an agonist antagonist is less likely to
cause side effects such as pruritus, respiratory depression, uri-
nary retention, excessive sedation, because of its action at
kappa receptors.
The aim of this study was to compare the combination of
0.125% (1 ml/kg) levobupivacaine and nalbuphine (0.2 mg/
kg) with levobupivacaine 0.25% (1 ml/kg) administeredAssessed for eligibility (n 
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Figure 1 CONSORT ﬂocaudally in young children with hernia repair surgeries for
reduction in dose of both agents and prolongation of the dura-
tion of analgesia.
It was hypothesized that the addition of nalbuphine to
levobupivacaine for caudal analgesia could hasten the onset
of action and could prolong the duration of analgesia.2. Patients and methods
This is a prospective randomized parallel-group controlled
study with allocation ratio (1:1) conducted after obtaining
written informed consent from the patients’ guardians and
obtaining approval from the ethical committee. A total of 40
patients aged 2–7 years, ASA physical status classiﬁcation
I–II undergoing elective hernia repair surgeries were enrolled.
Exclusion criteria included cardiac, asthmatic patients, proce-
dures lasting more than 90 min and allergy to any of study
drugs, and Fig. 1 shows ﬂowchart of the participants in the
study. General preoperative fasting guidelines were used. The
patients were randomly assigned two groups: L and LN
groups. Randomization was done using computer generated
random numbers inserted into opaque concealed envelopes;
inside these envelopes was a number, which indicates the group
to which the patient was assigned. Anesthesia was conducted
using Datex-Ohmeda anesthesia workstation (Datex-Ohmeda
Aspire 7100), (GE healthcare, Little Chalfont, UK). Standard
monitoring including electrocardiogram (ECG), non-invasive
blood pressure (NIBP), heart rate (HR) and oxygen saturation
was started preoperatively. Anesthesia was induced either
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Table 2 Demographic data and duration of procedure.
L Group
(n= 20)
LN Group
(n= 20)
P
value
Age (years) 4.4 ± 1.51 4.32 ± 1.34 0.989
Weight (kg) 14.6 ± 2.8 14.5 ± 3.03 0.850
Sex (female/male) 13/7 (65%) 9/11 (45%) 0.204
ASA classiﬁcation 1.2 ± 0.4 1.3 ± 0.47 0.471
Duration of
procedure
56.2 ± 9.16 56.25 ± 10.11 0.871
Data are expressed as mean ± SD (standard deviation) or count
and percentage.
Caudal nalbuphine in pediatric patients 85sevoﬂurane in oxygen. Tracheal intubation was done by using
atracurium 0.5 mg/kg body weight. Anesthesia was maintained
with 2% sevoﬂurane in oxygen. A caudal epidural block was
performed immediately after induction of anesthesia under
complete aseptic conditions; the anesthesiologist who per-
formed the caudal injections took no further part in the study.
Both patients and observers were blinded to the treatments.
Group LN received 0.125% levobupivacaine 1 ml/kg with nal-
buphine 0.2 mg/kg body weight. Group L patients received a
0.25% levobupivacaine 1 ml/kg. The total volume of mixture
injected caudally was remained constant in both groups i.e.
1 ml/kg body weight with maximum volume of 20 ml and max-
imum dose of levobupivacaine of 2 mg/kg. No other perioper-
ative analgesia was given. Anesthesia was discontinued when
the surgery was ﬁnished; residual neuromuscular block was
antagonized with neostigmine 0.05 lg/kg, given with atropine
0.02 mg/kg, and the endotracheal tube was removed after
return of spontaneous breathing. At PACU pain scores were
evaluated at arrival 0 h, 1, 2, 3, 4, 5, 6 and 12 h by the FLACC
pain scale (Table 1) [8]. For postoperative pain control parac-
etamol intravenous infusion was given if the recorded FLACC
pain score was 4 or more (with minimum 4 h time interval
between successive doses of paracetamol and rescue analgesia
with meperidine 0.5 mg/kg intravenously if the FLACC pain
score was 4 or more within this time interval). The time to ﬁrst
analgesic request [which was deﬁned as the time from extuba-
tion till the ﬁrst complaint of pain (Pain ScoreP 4)], the total
dose of paracetamol during the ﬁrst 12 h and the total dose of
meperidine rescue analgesic were recorded. Any episode of
complication like respiratory depression, vomiting or hypoten-
sion was recorded. FLACC pain scale is a measurement used
to assess pain in children between the ages of 2 months and
7 years or in individuals who are unable to communicate their
pain. The scale is scored in a range of 0–10, with 0 representing
no pain while 10 is the worst pain. The scale has ﬁve criteria
that are each assigned a score of 0, 1, or 2.
The primary outcome was the postoperative pain and
behavioral scores and the secondary outcome was the changes
of hemodynamic variables.
Sample size: Sample size calculation was done using PS
Power and Sample Size Calculations software, version 3.0.11
for MS Windows (William D. Dupont and Walton D. Vander-
bilt, USA). Assuming that power analysis with a error = 0.05,
b= 0.8 showed that we would need to study 15 patients in
each arm to reveal a signiﬁcant change in the duration ofTable 1 FLACC behavioral pain assessment scale [8].
Score
Parameters 0 1
Face No particular expression or
smile
Occasional grimace or fr
disinterested
Leg Normal position or relaxed Uneasy, restless, tense
Activity Lying quietly, normal
position, moves easily
Squirming, shifting back
Crying No cry (awake or asleep) Moans or whimpers, occ
Consolability Content, relaxed Reassured by occasional
being talked to; distracti
Score: 0, no pain; 1–3, mild pain; 4–7, moderate pain; 8–10, severe pain,analgesia as small as 1.5 times the standard deviation. The
sample size was increased by 30% (20 per arm) to account
for dropouts.
Statistical analysis: Data were coded and entered using the
statistical package SPSS version 22 (IBM Corporation,
Armonk, New York, USA). Data were summarized using
mean, standard deviation, median, minimum and maximum
for quantitative variables and frequencies (number of cases)
and relative frequencies (percentages) for categorical variables.
Comparisons between quantitative variables were done using
the nonparametric Mann–Whitney U test as the data in the
2 groups were non-normally distributed. For comparing cate-
gorical data, Chi square (v2) test was performed. Exact test was
used instead when the expected frequency is less than 5, and P-
values less than 0.05 were considered as statistically signiﬁcant.
3. Results
There was no statistically signiﬁcant difference between the
two groups regarding demographic data (age, sex, weight,
ASA physical status and duration of anesthesia) (Table 2).
No serious adverse effects were recorded in the ﬁrst 12 h in
all patients. No postoperative sedation, hallucination, nausea,
vomiting, allergy or signiﬁcant heart rate and blood pressure
changes were reported.
Postoperative FLACC pain scores were signiﬁcantly less in
LN group compared to L group after the second hour and in
the next time intervals (p< 0.05) (Table 3).
The ﬁrst time for postoperative analgesic requirement was
signiﬁcantly longer in LN group (384 ± 23.1 min) compared2
own; withdrawn, Frequent to constant frown, clenched
jaw, quivering chin
Kicking or legs drawn up
and forth, tense Arched, rigid, or jerking
asional complaint Crying steadily, screams or sobs;
frequent complaints
touching, hugging, or
ble
Diﬃcult to console or comfort
FLACC: face, legs, activity, cry, and consolability.
Table 3 Postoperative FLACC pain scores.
L group (n= 20) LN group (n= 20) P value
FLACC 0 h 1.00 (0.00–1.00) 0.50 (0.00–1.00) 0.086
FLACC 1 h 1.00 (1.00–2.00) 1.00 (0.50–2.00) 0.013
FLACC 2 h 2.00 (1.00–2.00) 1.00 (1.00–1.50) <0.001
FLACC 3 h 4.00 (3.00–4.00) 1.00 (1.00–2.00) <0.001
FLACC 4 h 4.00 (4.00–4.00) 1.50 (1.00–2.00) <0.001
FLACC 5 h 4.00 (4.00–5.00) 2.00 (2.00–3.00) <0.001
FLACC 6 h 4.00 (4.00–5.00) 3.00 (3.00–3.00) <0.001
FLACC 12 h 4.00 (4.00–4.50) 4.00 (3.00–4.00) 0.001
Data are expressed as median and interquartile range (IQR),
FLACC: face, legs, activity, cry, and consolability.
Table 4 Time to 1st rescue analgesic (min) and total dose of
paracetamol (mg).
L Group
(n= 20)
LN Group
(n= 20)
P value
Time to 1st rescue
analgesic (min)
202 ± 23.42 384.9 ± 23 <0.001
Total dose of
paracetamol in the 1st
12 h (mg)
355.25 ± 69.9 200.5 ± 75.65 <0.05
Data are expressed as mean ± SD (standard deviation).
86 A.K. Salamato L group (202.20 ± 23.42 min) (p value > 0.001). The total
dose of postoperative supplementary analgesia (intravenous
paracetamol infusion) in the ﬁrst 12 h was signiﬁcantly lower
in LN group (200.5 ± 65.5 mg) in comparison with L group
(355.25 ± 69.9 mg) (P< 0.05) (Table 4). Meperidine as a sec-
ond rescue analgesic was not required by any patient in the two
studied groups.
4. Discussion
The present study demonstrated that the use of epidural nal-
buphine as adjuvant to levobupivacaine for postoperative
analgesia after hernia repair surgeries is safe and effective with
reduced postoperative FLACC pain scores and analgesic
request during the ﬁrst 12 h compared to levobupivacaine
alone and longer duration of postoperative analgesia. Nal-
buphine is a mixed agonist–antagonist opioid which has antag-
onist effect at mu receptor and agonist at kappa receptors.
There are few reports of neuraxial administration of nal-
buphine. There are no reports of neurotoxicity of intrathecal
nalbuphine since then. Intrathecal nalbuphine was used in
pregnant patients, but no neurotoxicity was reported in them
[9]. Previous studies also have shown that epidural or intrathe-
cal use of nalbuphine produces a signiﬁcant analgesia accom-
panied by minimal itching and respiratory depression [10].
In the present study we have used levobupivacaine with nal-
buphine as an adjuvant to assess the duration of analgesia
postoperatively and any side effects. After caudal block was
given there was no signiﬁcant difference between onset of sen-
sory and motor block in both of the groups. There was also no
signiﬁcant difference between peak sensory and motor block in
both groups but duration of postoperative analgesia in study
group with added adjuvant nalbuphine was 6–8 h and in con-trol group with plain levobupivacaine was 2–3 h. This is the
ﬁrst study to evaluate the effect of adding nalbuphine to the
caudal epidural route in children.
In line with our study Shin et al. [11] assessed caudal nal-
buphine as a postoperative analgesic in a randomized double
blind study of 80 patients after perianal surgery. Caudal block
was carried out with 1.5% lidocaine; 25 ml (Group 1) in 20
patients, and mixed with nalbuphine 3 mg (Group 2) in 20
patients, nalbuphine 5 mg (Group 3) in 20 patients, and nal-
buphine 10 mg (Group 4) in 20 patients. Pain relief was evalu-
ated by the subsequent need for systemic analgesics
(Pethidine). In group 4, the use of systemic analgesics was sig-
niﬁcantly reduced for the ﬁrst 24 h postoperatively.
Also, in line with our study Lippmann and colleagues [12]
studied efﬁcacy of epidural nalbuphine in postoperative pain
control. They used 10 mg nalbuphine in 10 ml normal saline
compared to 10 ml normal saline in the epidural space during
postoperative period after full recovery from effect of anesthe-
sia and at complaining of severe pain. Patients’ pain intensities
were evaluated by visual analogue scale (VAS) and numbers of
intramuscular analgesics needed were recorded through the
48 h observation period. They found that pain scores were sig-
niﬁcantly lower in the nalbuphine group (p-value < 0.05) (no
patient in the nalbuphine group required intramuscular anal-
gesics in the 1st 6 h, whereas 65% of the patient in the control
group required analgesics), no evidence of sensory, motor or
autonomic block was observed in any patient, also no pruritus
or respiratory depression was noticed in any patient.
Limitation of this study was the duration of follow-up of
patients as we followed them for 12 h only as surgeries were
done on day case basis. In this study we used doses of nal-
buphine comparable to those used for intravenous analgesic
therapy. Thus our results may reﬂect systemic effects. We can-
not conclude this with certainty, because we did not estimate
blood levels of nalbuphine.
In conclusion we found that addition of nalbuphine to local
anesthetic was associated with prolonged duration of analgesia
and reduced analgesic requirements and no side effects were
observed.
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